ATE454398T1 - Sperm faktoren sequenzen - Google Patents

Sperm faktoren sequenzen

Info

Publication number
ATE454398T1
ATE454398T1 AT02801948T AT02801948T ATE454398T1 AT E454398 T1 ATE454398 T1 AT E454398T1 AT 02801948 T AT02801948 T AT 02801948T AT 02801948 T AT02801948 T AT 02801948T AT E454398 T1 ATE454398 T1 AT E454398T1
Authority
AT
Austria
Prior art keywords
acid sequence
sequences
nucleic acid
sequence
hybridizes
Prior art date
Application number
AT02801948T
Other languages
English (en)
Inventor
Tony Lai
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0125498A external-priority patent/GB0125498D0/en
Priority claimed from GB0214945A external-priority patent/GB0214945D0/en
Application filed by Univ Cardiff filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE454398T1 publication Critical patent/ATE454398T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
AT02801948T 2001-10-24 2002-10-18 Sperm faktoren sequenzen ATE454398T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0125498A GB0125498D0 (en) 2001-10-24 2001-10-24 Sequences
GB0214945A GB0214945D0 (en) 2002-06-28 2002-06-28 Sequences
PCT/GB2002/004739 WO2003035678A2 (en) 2001-10-24 2002-10-18 Sperm factor sequences

Publications (1)

Publication Number Publication Date
ATE454398T1 true ATE454398T1 (de) 2010-01-15

Family

ID=26246693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02801948T ATE454398T1 (de) 2001-10-24 2002-10-18 Sperm faktoren sequenzen

Country Status (7)

Country Link
US (1) US20050112575A1 (de)
EP (1) EP1440084B1 (de)
JP (1) JP4324473B2 (de)
AT (1) ATE454398T1 (de)
CA (1) CA2461543C (de)
DE (1) DE60235027D1 (de)
WO (1) WO2003035678A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097182A1 (ja) * 2004-04-05 2005-10-20 The University Of Tokushima 経粘膜及び経皮投与を可能にする抗原薬物ヴィークル、これを用いる粘膜免疫の誘導方法、粘膜ワクチン及びdds
WO2008063577A2 (en) * 2006-11-17 2008-05-29 University Of Massachusetts Phospholipase c zeta mediated oocyte activation
GB0715325D0 (en) * 2007-08-08 2007-09-19 Univ Cardiff Fertilisation protein
CA2708333A1 (en) * 2007-12-12 2010-02-11 The Lubrizol Corporation Marine diesel cylinder lubricants for improved fuel efficiency
US8735359B2 (en) * 2012-05-24 2014-05-27 Orban Biotech Llc Combinations of modalities for the treatment of diabetes
MX2015000237A (es) 2012-06-27 2015-08-14 Orban Biotech Llc Proteinas de fusion ctla4 para el tratamiento de la diabetes.
GB2523399B (en) 2014-02-25 2019-03-13 Orban Tihamer A composition comprising ten overlapping peptide fragments of the entire preproinsulin sequence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4724996A (en) * 1995-02-16 1996-09-04 Medical Research Council Sperm factor
WO2002006302A2 (en) * 2000-07-17 2002-01-24 Millennium Pharmaceuticals, Inc. 16816 and 16839, novel human phospholipase c molecules and uses therefor

Also Published As

Publication number Publication date
EP1440084A2 (de) 2004-07-28
WO2003035678A3 (en) 2003-06-26
CA2461543C (en) 2015-07-07
JP4324473B2 (ja) 2009-09-02
CA2461543A1 (en) 2003-05-01
JP2005522987A (ja) 2005-08-04
WO2003035678A2 (en) 2003-05-01
DE60235027D1 (de) 2010-02-25
EP1440084B1 (de) 2010-01-06
US20050112575A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
EP0994191A4 (de) System zum exprimieren einer hyperthermostabilen protease
ATE420653T1 (de) Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
AR010340A1 (es) COMPOSICIoN PARA HORNEADO, USO DE DICHA COMPOSICIoN Y USO DEL POLIPÉPTIDO DE DICHA COMPOSICIoN.
ATE258060T1 (de) Tadg15: eine extrazelluläre serinprotease überexprimiert in brust- und eierstock-karzinomen
DE60128093D1 (de) Interferon-ähnliches protein zcyto21
BR0213411A (pt) Proteìna de metabolização de herbicida, seu gene e uso
TW200716166A (en) Lawsonia intracellularis immunological proteins
ATE454398T1 (de) Sperm faktoren sequenzen
Egelseer et al. Characterization of an S-layer glycoprotein produced in the course of S-layer variation of Bacillus stearothermophilu s ATCC 12980 and sequencing and cloning of the sbsD gene encoding the protein moiety
DK1085094T3 (da) Nucleotidsekvenser, som koder for dapF-genet
ATE196926T1 (de) Gen grb3-3, variante und ihre verwendungen
ATE452184T1 (de) Mikrobielle trypsinvarianten mit chymotrypsinaktivität und diese codierende nukleinsäuren
ATE414156T1 (de) Lipase-varianten
DK1007627T3 (da) Extracellulær serinprotease
SE9801098D0 (sv) Receptors
AU7655994A (en) Cloning of a member of the serine-threonine-kinase family
ATE441708T1 (de) An der zytokininsynthese beteiligte proteine codierende gene
HUP0001969A2 (hu) Az NNT-1 neurotróf faktor
DK1425295T3 (da) Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme
SE0101519D0 (sv) Nucleic ACID
CA2318490A1 (en) A novel gene for controlling leaf shapes
EP1568775A4 (de) Krebs-assoziiertes gen
AU2003277889A1 (en) A gene encoding vitamin b6 phosphate phosphatase and use thereof
AU5260801A (en) Novel (r)-2-hydroxy-3-phenylpropionate (d-phenyllactate) dehydrogenase and gene encoding the same
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties